Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
34 Results for "
glycoprotein-IIb
" in MedChemExpress (MCE) Product Catalog:
Products (34)
34 Results for "glycoprotein-IIb" in MCE Product Catalog:
9
9 Publications Verification
Cat. No.: HY-B0686
CAS No.: 188627-80-7
Target:
Research Areas:
9
9 Publications Verification
Cat. No.: HY-B0686B
CAS No.: 881997-86-0
Target:
Research Areas:
3
Target:
Research Areas:
3
3 Cited Publications
Cat. No.: HY-P0074A
CAS No.: 157009-81-9
Synonyms: Gly-Pro-Arg-Pro acetate; Pefa 6003 acetate
Target:
Research Areas:
2
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P77716
Purity: ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: ITGA2B; Platelet Fibrinogen Receptor, Alpha Subunit; Prev. GP2B; Platelet glycoprotein IIb; GPIIb; AlphaIIb Protein; Integrin Alpha-IIb; glycoprotein IIb; PPP1R93; CD41 Antigen; CD41B; BDPLT16; CD41; BDPLT2; Integrin, Alpha 2b (Platelet glycoprotein IIb O
Cat. No.: HY-146332
CAS No.: 104260-73-3
Target:
Research Areas:
Collagen-IN-1 (compound 3), an ortho-carbonyl hydroquinone derivative, is a selective inhibitor on collagen. Collagen-IN-1 inhibits agonist-induced platelet aggregation in a non-competitive manner with an IC50 value of 1.77 μM. Collagen-IN-1 reduces the expression of P-selectin, activation of glycoprotein IIb/IIIa, and release of adenosine triphosphate and CD63 from platelet. Collagen-IN-1 has the potential for platelet-related thrombosis diseases research .
Cat. No.: HY-B0686A
CAS No.: 1248559-53-6
Target:
Research Areas:
Cat. No.: HY-10305
CAS No.: 149820-74-6
Target:
Research Areas:
Xemilofiban is an orally active glycoprotein IIb/IIIa blocking agent. Xemilofiban inhibits platelet aggregation. Xemilofiban reduces the incidence of thrombosis .
Synonyms: RO 48-3657
Target:
Research Areas:
Sibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregation .
Cat. No.: HY-10309R
CAS No.: 172927-65-0
Synonyms: RO 48-3657 (Standard)
Target:
Research Areas:
Sibrafiban (Standard) is the analytical standard of Sibrafiban. This product is intended for research and analytical applications. Sibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregation .
Cat. No.: HY-101720
CAS No.: 148396-36-5
Synonyms: BIBU-52
Target:
Research Areas:
Fradafiban is a nonpeptide platelet glycoprotein IIb/IIIa antagonist, which binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM.
Cat. No.: HY-101720A
Purity: 99.96%
Synonyms: BIBU-52 hydrochloride
Target:
Research Areas:
Fradafiban (BIBU-52) hydrochloride is a nonpeptide platelet glycoprotein IIb/IIIa antagonist, which binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM.
Cat. No.: HY-10308
CAS No.: 149503-79-7
Target:
Research Areas:
Lefradafiban is an orally active glycoprotein IIb/IIIa receptor antagonist. Lefradafiban can be metabolized to its active form, Fradafiban, a non-peptide GP IIb/IIIa receptor antagonist .
Cat. No.: HY-111348
CAS No.: 144412-49-7
Synonyms: Ro 44-9883
Target:
Research Areas:
Lamifiban is a nonpeptide glycoprotein IIb/IIIa receptor and platelet aggregation antagonist. Lamifiban in combination with thrombolytic therapy effectively restores coronary arterial patency. Lamifiban is promising for research of acute coronary syndromes .
Cat. No.: HY-108881R
CAS No.: 2751-09-9
Synonyms: Triacetyloleandomycin (Standard)
Research Areas:
Eptifibatide (acetate) (Standard) is the analytical standard of Eptifibatide (acetate). This product is intended for research and analytical applications. Eptifibatide acetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity .
Cat. No.: HY-B0686BR
CAS No.: 881997-86-0
Target:
Research Areas:
Cat. No.: HY-111348A
CAS No.: 144412-50-0
Target:
Research Areas:
Lamifiban TFA is a nonpeptide glycoprotein IIb/IIIa receptor and platelet aggregation antagonist. Lamifiban TFA in combination with thrombolytic therapy effectively restores coronary arterial patency. Lamifiban TFA is promising for research of acute coronary syndromes .
Cat. No.: HY-U00235
CAS No.: 180144-61-0
Target:
Research Areas:
SR121566A is a novel non-peptide Glycoprotein IIb/IIIa (GP IIb-IIIa) antagonist, which can inhibit ADP-, arachidonic acid- and collagen-induced human platelet aggregation with IC50s of 46±7.5, 56±6 and 42±3 nM, respectively.
Cat. No.: HY-126039
CAS No.: 168157-33-3
Target:
Research Areas:
L-739758 is an antagonist for αIIbβ3 integrin (platelet glycoprotein IIb/IIIa). L-739758 acts as a peptidomimetic, binds to αIIbβ3 integrin by mimicking the interaction of the RGD (arginine-glycine-aspartic acid) motif, and is involved in the blood coagulation process. L-739758 inhibits platelet aggregation, and is used for thrombosis research .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
